U.S. Court of Appeals for the Federal Circuit, 2018

Par Pharmaceutical, Inc. v. Horizon Therapeutics, LLC

Par Pharmaceutical, Inc. v. Horizon Therapeutics, LLC
U.S. Court of Appeals for the Federal Circuit · Decided June 18, 2018

Par Pharmaceutical, Inc. v. Horizon Therapeutics, LLC

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ PAR PHARMACEUTICAL, INC., Appellant v. HORIZON THERAPEUTICS, LLC, Appellee ______________________ 2017-1451 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2015- 01117, IPR2016-00283. ______________________ JUDGMENT ______________________ AZIZ BURGY, Axinn, Veltrop & Harkrider LLP, Wash- ington, DC, argued for appellant. Also represented by THOMAS K. HEDEMANN, Hartford, CT; DAVID H.

SILVERSTEIN, New York, NY.

ROBERT FRITZ GREEN, Green, Griffith & Borg-Breen LLP, Chicago, IL, argued for appellee. Also represented by EMER LOUISE SIMIC; JAMES B. MONROE, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washing- ton, DC; MATTHEW CARMINE PHILLIPS, Laurence & Phil- lips IP Law LLP, Portland, OR. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (NEWMAN, DYK, and TARANTO, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

June 18, 2018 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.